Proxy Materials

Certara, Inc. Filed 2024-04-10 Acc 0001104659-24-045507

Documents 1

2024-04-12 DEFA14A Proxy Materials
2024-04-10 ARS Annual Report to Security Holders
2024-04-10 DEFA14A Proxy Materials
2024-04-10 DEF 14A Proxy Statement
2024-04-05 4/A Options or other derivatives
2024-04-04 4 PRESIDENT, DRUG DEV SOLUTIONS sold 14,427 shares at an average $16.85 ($243,161)
2023-04-10 DEFA14A Proxy Materials

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading tm242785d4_defa14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…